Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation (Q60685688)
Jump to navigation
Jump to search
scientific article published on 01 January 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation |
scientific article published on 01 January 2001 |
Statements
Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation (English)
P Colombat
G Salles
N Brousse
P Eftekhari
V Delwail
E Deconinck
C Foussard
C Sebban
A Stamatoullas
F Boué
B Taillan
P Lederlin
A Najman
C Thièblemont
F Montestruc
A Mathieu-Boué
A Benzohra
P Solal-Céligny